Dolby Laboratories (DLB) vs Transcat (TRNS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Transcat (TRNS) has outperformed Dolby Laboratories (DLB) over the past year, gaining 25.7% versus a loss of 16.6%. Over five years, TRNS leads with a +25.4% price change compared with -35.0% for DLB. Dolby Laboratories is the larger company by market cap ($5.51 billion vs $827.1 million), about 6.7 times the size.
On valuation, Dolby Laboratories trades at a lower forward P/E (12.8x vs 40.8x for Transcat). Dolby Laboratories pays a dividend yielding 2.45%, while Transcat does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DLB | TRNS |
|---|---|---|
| Share price | $58.85 | $88.37 |
| Market cap | $5.51B | $827.09M |
| 1-day change | +0.86% | -0.48% |
| YTD return | -9.14% | +56.51% |
| 1-year return | -16.56% | +25.69% |
| 5-year return | -35.00% | +25.43% |
| P/E ratio (TTM) | 25.04 | 245.46 |
| Forward P/E | 12.85 | 40.77 |
| EPS (TTM) | $2.35 | $0.36 |
| Dividend yield | 2.45% | 0.00% |
| Annual dividend | $1.44 | $0.00 |
| Revenue (latest FY) | $1.35B | — |
| Revenue growth (YoY) | +5.92% | — |
| Net income (latest FY) | $255.02M | — |
| Gross margin | 88.13% | — |
| Operating margin | 19.64% | — |
| Net margin | 18.90% | — |
| 52-week high | $71.24 | $100.00 |
| 52-week low | $48.26 | $50.23 |
| Distance from 52-week high | -17.39% | -11.63% |
| Analyst consensus | none | none |
| Avg. price target upside | +34.24% | +18.07% |
| Average volume | 924.99K | 123.05K |
| Shares outstanding | 59.42M | 9.36M |
| Employees | 2,051 | 1,413 |
| Sector | Miscellaneous | Industrials |
| Industry | Multi-Sector Companies | Electrical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Dolby Laboratories is about 6.7 times larger than Transcat by market value ($5.51B vs $827.09M).
- TRNS has outperformed DLB by 42.3 percentage points over the past year.
- Transcat trades at a higher earnings multiple (245.5x vs 25.0x trailing P/E).
- Dolby Laboratories offers a meaningfully higher dividend yield (2.45% vs 0.00%).
- The two companies sit in different sectors: Dolby Laboratories in Miscellaneous and Transcat in Industrials.
About Dolby Laboratories
DLB stock →Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally.
Miscellaneous · Multi-Sector Companies · 2,051 employees
About Transcat
TRNS stock →Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally.
Industrials · Electrical Products · 1,413 employees
DLB vs TRNS FAQ
Which is bigger, Dolby Laboratories or Transcat?
Dolby Laboratories (DLB) is larger, with a market capitalization of $5.51B compared with $827.09M for Transcat (TRNS).
Which stock has performed better over the past year, DLB or TRNS?
TRNS returned +25.69% over the past 12 months, compared with -16.56% for DLB (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DLB or TRNS?
DLB has the lower trailing P/E at 25.0, versus 245.5 for TRNS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Dolby Laboratories or Transcat?
Dolby Laboratories pays a dividend yielding 2.45%, while Transcat does not currently pay a regular dividend.
Are Dolby Laboratories and Transcat in the same industry?
No. Dolby Laboratories is in the Miscellaneous sector, while Transcat is in Industrials.